| Severe lesions n (%) | Odds ratio | 95% CI | P-value |
Age, years (>50 for men; >60 for women) | 283 (74.3) | 2.31 | 1.52 - 3.15 | <0.001 |
History of acute coronary syndrome | 28 (82.3) | 2.12 | 0.86 - 5.24 | 0.09 |
Male sex | 295 (73.0) | 2.10 | 1.34 - 3.28 | <0.001 |
Left ventricular dysfunction | 162 (45.9) | 1.93 | 1.29 - 2.88 | 0.001 |
Renal failure | 71 (20.1) | 1.90 | 1.09 - 3.32 | 0.02 |
Diabetes | 207 (75.8) | 1.89 | 1.28 - 2.77 | 0.001 |
High Framingham risk score | 68 (19.3) | 1.69 | 0.98 - 2.93 | 0.05 |
Diabetes duration | 82 (77.4) | 1.63 | 0.99 - 2.70 | 0.05 |
High European risk score | 84 (23.8) | 1.54 | 0.94-2.50 | 0.08 |
Smoking | 149 (42.2) | 1.39 | 0.94 - 2.06 | 0.09 |
Elevated triglycerides | 139 (39.4) | 1.35 | 0.90 - 2.01 | 0.13 |
Low HDL | 219 (62.0) | 1.13 | 0.76 - 1.66 | 0.53 |
Pulmonary arterial hypertension | 86 (24.4) | 1.09 | 0.69-1.71 | 0.69 |
Arterial hypertension | 157 (44.5) | 0.96 | 0.65 - 1.40 | 0.83 |
Abdominal obesity | 212 (60.1) | 0.86 | 0.58 - 1.27 | 0.44 |
Obesity | 73 (20.7) | 0.70 | 0.45 - 1.08 | 0.11 |
History of coronary disease | 35 (9.9) | 0.66 | 0.37 - 1.16 | 0.15 |
Dyslipidemia | 32 (9.1) | 0.59 | 0.33 - 1.06 | 0.08 |
Lipid-lowering treatment | 24 (6.8) | 0.55 | 0.28 - 1.04 | 0.06 |